IATERION, INC.
Biotech · Private
estrogen receptor reprogramming ligands combined with estradiol for safer menopausal hormone therapy
- Grants
- $735K
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 28
- 0 granted · 28 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620172018201920202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Estrogen Receptor Coligand Reprogramming of Menopausal Hormone Therapy | $180,129 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of reprogramming ligands for menopausal hormone therapy | $255,543 | |
| Federal grant | Department of Health and Human Services · Phase I · Estrogen receptor reprogramming ligands for the prevention of protracted menopausal symptoms and chronic diseases | $298,883 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1142 | REZIGENE, LLC | — | — |
| 1143 | Optivia Biotechnology Inc. | — | — |
| 1144 | Reveris Therapeutics | — | — |
| 1145 | IATERION, INC. | — | — |
| 1146 | RAZI PHARMA LLC | — | — |
| 1147 | Character Bio | — | — |
| 1148 | Vulcan Biologics, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods And Compositions For Treating Viral Infectionsapplication
- Methods And Compositions For Treating Viral Infections With Double And Triple Combinations Of Antiviral And Immune Modulating Compoundsapplication
- Estrogenic Compounds And Methods Of Useapplication
- Er-beta Estrogenic Compounds And Methods Of Useapplication
- Methods And Compositions For Treating Viral Infections With Double And Triple Combinations Of Antiviral And Immune Modulating Compoundsapplication
- Methods And Compositions For Treating Viral Infectionsapplication
- Methods And Compositions For Treating Viral Infections With Helichrysetinapplication
- Methods And Compositions For Treating Viral Infections With Formononetinapplication
- Methods And Compositions For Treating Viral Infections With Cinnamanilideapplication
- Methods And Compositions For Treating Viral Infections With, Tetrandrine, Cepharanthine And Penta-o-galloyl-beta-d-glucose Hydrateapplication
- Methods And Compositions For Treating Viral Infections With Combinations Of Tetrandrine And Cepharanthineapplication
- Methods And Compositions For Treating Viral Infections With Kazinol Aapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.